This special mechanism induces a synergistic result with Improved insulin response and glucagonostatic exercise, vs . GIP or GLP-1 therapy by itself. Summary Tirzepatide is a whole new molecule effective at managing glucose blood levels by combining the dual agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors. https://psychedelics85086.theisblog.com/28291086/details-fiction-and-chemical-research-in-toxicology